Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 630 Prostatic Neoplasms 372 Neoplasms 305 Carcinoma, Non-Small-Cell Lung 215 Lung Neoplasms 204 Colorectal Neoplasms 176 Multiple Myeloma 143 Pancreatic Neoplasms 136 Leukemia, Myeloid, Acute 128 Neoplasm Metastasis 124 Brain Neoplasms 117 Melanoma 116 Ovarian Neoplasms 101 Carcinoma, Hepatocellular 101 Precursor Cell Lymphoblastic Leukemia-Lymphoma 100 Glioblastoma 99 Uterine Cervical Neoplasms 97 Head and Neck Neoplasms 94 Squamous Cell Carcinoma of Head and Neck 93 Colonic Neoplasms 82 Stomach Neoplasms 80 Recurrence 80 Rectal Neoplasms 80 Urinary Bladder Neoplasms 77 Sarcoma 77 Carcinoma, Renal Cell 76 Triple Negative Breast Neoplasms 75 Lymphoma 71 Lymphoma, Non-Hodgkin 67 Leukemia, Lymphocytic, Chronic, B-Cell 66

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × High-Risk Cancer × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡